A new guideline for administering platelet transfusions to adult patients emphasizes judicious use of the procedure to reduce patient risk and conserve resources, according to an article published ...
A randomized trial compared prophylactic platelet transfusion with transfusion given when bleeding occurred. Decreased platelet usage was noted in the therapeutic transfusion group with a very low ...
65.4% of hospitalized ITP inpatients did not have a bleeding episode or surgical procedure associated with their platelet transfusion. Platelet transfusions were not associated with improved clinical ...
A group of 12 thrombocytopenic patients, ranging in age from two to fourteen years, were studied. The thrombocytopenia was due to diverse conditions (Table 1). The platelet count ranged from 3000 to ...
Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...
To provide evidence-based guidance on the use of platelet transfusion in people with cancer. This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in ...
THE hemorrhagic tendency of thrombocytopenic animals can be controlled temporarily by transfusions of fresh platelet concentrates. 1,2 The clinical value of platelet transfusions has previously been ...
WASHINGTON -- The FDA approved another thrombopoietin receptor agonist on Monday, for an indication not covered by other drugs intended to raise platelet counts. The new agent is avatrombopag ...
Blood transfusions are an essential component of modern medicine. Every two seconds, someone in the United States needs a blood transfusion, and the importance of this life saving procedure has ...
To provide evidence-based guidance on the use of platelet transfusion in people with cancer. This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results